Key Data Points

Primary metrics and data points about Galectin Therapeutics Inc..
Current Price: $3.54
Prev Close: $3.55
Open: $3.56
Bid: $3.12
Ask: $4.30
Day's Range: $3.50 - $3.73
52wk Range: $3.00 - $17.14
Volume: 63,423
Avg Vol 135,480
Market Cap: $83M
P/E (ttm): -4.55
EPS (ttm): ($0.78)
Div & Yield: $0.00 (0.0%)

Business Summary

Industry, sector and description for Galectin Therapeutics Inc..

A development stage pharmaceutical company engaged in the discovery, development and commercialization of carbohydrate-based therapeutic compounds for advanced treatment of cancer, liver, microbial, cardiovascular and inflammatory diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

GALT vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Galectin Therapeutics Inc..
CAPS Rating 1 out of 5
 
55 Outperform
48 Underperform
CAPS All Stars
 
10 Outperform
33 Underperform

Powered by Motley Fool CAPS


More Details about Galectin Therapeutics Inc.

Primary metrics and data points about Galectin Therapeutics Inc..

Company Photos

Powered by